×
Volver a Agendas
Session Chair(s)
Kenji Adachi, PhD
Medical Affairs - Health Economics and Outcomes Research
Gilead Sciences, Inc., Japan
Speaker(s)
Clinical Trial Design, Analysis and Reporting Strategies to Maximize Reimbursement Success <Remote Presentation via Internet>
Christine Fletcher, MSc
GlaxoSmithKline, United Kingdom
VP/Head, Speciality and Primary Care Statistics
Patient-Centric Postmarketing Studies on Safety, Effectiveness and Value
Nancy Dreyer, PhD, MPH, FISPE
Dreyer Strategies LLC, United States
Founder
What Should We Do During Drug Development and Postmarketing When Introducing HTA in Japan?
Kotoba Okuyama
MSD K.K., Japan
Sr. Biometrician, Biostatistics and Research Decision Sciences
TBA
Toshihiko Aranishi, PhD
Eli Lilly Japan K.K, Japan
Research Scientist, Health Outcomes/Health Technology Assessment
Current HTA Discussion for Japan’s Health Care Policy, and Roles of Academia
Takeru Shiroiwa, PhD
National Institute of Public Health, Japan
Senior Researcher, Department of Health and Welfare Services
¿Tiene una cuenta?